NanoVibronix, Inc. (NAOV) DCF Valuation

NanoVibronix, Inc. (NAOV) DCF Valuation

US | Healthcare | Medical - Devices | NASDAQ
NanoVibronix, Inc. (NAOV) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

NanoVibronix, Inc. (NAOV) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Streamline your analysis and improve precision with our (NAOV) DCF Calculator! Equipped with real data from NanoVibronix, Inc. and customizable assumptions, this tool empowers you to forecast, analyze, and assess (NAOV) like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .5 .6 1.7 .8 2.3 3.2 4.5 6.3 8.9 12.5
Revenue Growth, % 0 17.55 172.07 -55.63 203.59 40.48 40.48 40.48 40.48 40.48
EBITDA -5.7 -4.2 -14.2 -5.0 -3.4 -3.2 -4.5 -6.3 -8.9 -12.5
EBITDA, % -1083.96 -668.06 -840.59 -666.49 -150.46 -100 -100 -100 -100 -100
Depreciation .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 0.75472 0.32103 0.11799 0.13298 0.04380201 0.2741 0.2741 0.2741 0.2741 0.2741
EBIT -5.7 -4.2 -14.3 -5.0 -3.4 -3.2 -4.5 -6.3 -8.9 -12.5
EBIT, % -1084.72 -668.38 -840.71 -666.62 -150.5 -100 -100 -100 -100 -100
Total Cash 1.3 7.1 7.7 2.7 3.3 3.2 4.5 6.3 8.9 12.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 .1 .3 .1 .4
Account Receivables, % 24.53 14.93 15.58 14.49 18.62
Inventories .1 .1 .2 2.2 2.7 1.6 2.3 3.2 4.6 6.4
Inventories, % 22.83 23.27 10.32 289.23 119.67 51.29 51.29 51.29 51.29 51.29
Accounts Payable .1 .1 .1 .1 .1 .4 .6 .9 1.2 1.7
Accounts Payable, % 24.34 23.11 5.13 8.78 6.04 13.48 13.48 13.48 13.48 13.48
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 0 -0.32103 -0.17699 -0.39894 -0.04380201 -0.18815 -0.18815 -0.18815 -0.18815 -0.18815
Tax Rate, % -0.78762 -0.78762 -0.78762 -0.78762 -0.78762 -0.78762 -0.78762 -0.78762 -0.78762 -0.78762
EBITAT -5.7 -4.2 -14.3 -5.0 -3.5 -3.2 -4.5 -6.3 -8.9 -12.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.9 -4.2 -14.5 -6.9 -4.3 -2.0 -5.2 -7.3 -10.3 -14.5
WACC, % 35.57 35.64 35.64 35.64 35.64 35.62 35.62 35.62 35.62 35.62
PV UFCF
SUM PV UFCF -13.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -15
Terminal Value -44
Present Terminal Value -10
Enterprise Value -23
Net Debt -3
Equity Value -20
Diluted Shares Outstanding, MM 2
Equity Value Per Share -11.26

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real NanoVibronix, Inc. (NAOV) financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the highlighted cells).
  • Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Quickly observe how your inputs affect NanoVibronix, Inc. (NAOV)’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step guidance.

Key Features

  • 🔍 Real-Life NAOV Financials: Pre-filled historical and projected data for NanoVibronix, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate NanoVibronix’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize NanoVibronix’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered NanoVibronix data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for NanoVibronix's intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for NanoVibronix, Inc. (NAOV)?

  • Accurate Data: Utilize real NanoVibronix financials for trustworthy valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you from starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the field.
  • User-Friendly: An intuitive design and guided instructions make it accessible for all users.

Who Should Use This Product?

  • Healthcare Professionals: Enhance patient treatment plans with innovative ultrasound technology.
  • Researchers: Utilize advanced data to explore the efficacy of non-invasive therapies.
  • Investors: Evaluate potential growth and market strategies for NanoVibronix, Inc. (NAOV).
  • Medical Device Analysts: Optimize analysis processes with tailored models for product performance.
  • Small Business Owners in Healthcare: Understand how emerging technologies impact patient care and market trends.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for NanoVibronix, Inc. (NAOV).
  • Real-World Data: NanoVibronix's historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to NanoVibronix, Inc. (NAOV).
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results.

No products were found matching.